356565.1

LITE DEPALMA GREENBERG, LLC

Allyn Z. Lite

Mayra V. Tarantino

Two Gateway Center, Suite 1201

Newark, NJ 07102

(973) 623-3000

alite@litedepalma.com

mtarantino@litedepalma.com

Attorneys for Defendants and CounterclaimPlaintiffs Hanmi USA, Inc., Hanmi Pharmaceutical 

Co., Ltd., Hanmi Fine Chemical Co., Ltd. and 

Hanmi Holdings Co., Ltd.

IN THE UNITED STATES DISTRICT COURT

THE DISTRICT OF NEW JERSEY

ASTRAZENECA AB, AKTIEBOLAGET 

HÄSSLE, ASTRAZENECA LP, KBI INC., 

and KBI-E INC.,

Plaintiffs and 

 Counterclaim Defendants,

v.

HANMI USA, INC., HANMI 

PHARMACEUTICAL CO., LTD., HANMI 

FINE CHEMICAL CO., LTD, and HANMI 

HOLDINGS CO., LTD.,

Defendants and 

 Counterclaim Plaintiffs.

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

Civil Action No. 11-760 (JAP)(TJB)

NOTICE OF MOTION 

TO: COUNSEL OF RECORD

PLEASE TAKE NOTICE that on a May 13, 2013 at 10:00 a.m. or as soon thereafter as 

counsel may be heard, Defendants Hanmi USA, Inc., Hanmi Pharmaceutical Co., Ltd., Hanmi 

Fine Chemical Co., Ltd. and Hanmi Holdings Co., Ltd. (collectively, “Hanmi”), will move 

before the Honorable Joel A. Pisano, U.S.D.J. at the U.S. District Court for the District of New 

Jersey, Clarkson S. Fisher Federal Bldg. & U.S. Courthouse, 402 East State Street, Trenton, New 

Jersey, for an order granting the following: 

Case 3:11-cv-00760-JAP-TJB Document 290 Filed 04/29/13 Page 1 of 3 PageID: 10240
2

356565.1

1. Hanmi’s Motion in Limine No. 1(To Preclude Testimony of Judi Weissinger)

and Motion to Strike Weissinger Report.

2. Hanmi’s Motion in Limine No. 2 (To Preclude New Case Theories Never Disclosed 

In AstraZeneca's Contentions).

3. Hanmi’s Motion in Limine No. 3 (To Preclude AstraZeneca From Attempting To 

Establish a Filing Date for the ‘192 Patent Earlier Than April 11, 1997).

4. Hanmi’s Motion in Limine No. 4 (To Preclude AstraZeneca From Attempting To 

Introduce Evidence Alleging Invalidity or Unenforceability of Hanmi’s Patents).

5. Hanmi’s Motion in Limine No. 5 (To Preclude Testimony of Dr. Paul Bartlett).

6. Hanmi’s Motion in Limine No .6 (To Preclude AstraZeneca From Attempting To 

Introduce Evidence On Theories Not In Its Contentions ).

PLEASE TAKE FURTHER NOTICE that in support of Hanmi’s Motions in Limine, 

Hanmi will rely upon the Memoranda of Law submitted with this Notice of Motion, and upon all 

pleadings and proceedings on file herein.

PLEASE TAKE FURTHER NOTICE that a proposed form of order granting Hanmi’s 

motions is submitted herewith.

Dated: April 29, 2013 LITE DEPALMA GREENBERG, LLC

s/Mayra V. Tarantino

Allyn Z. Lite

Mayra V. Tarantino

Two Gateway Center, Suite 1201

Newark, NJ 07102

(973) 623-3000

alite@litedepalma.com

mtarantino@litedepalma.com

Case 3:11-cv-00760-JAP-TJB Document 290 Filed 04/29/13 Page 2 of 3 PageID: 10241
3

356565.1

SUGHRUE MION, PLLC

Mark Boland

Michael R. Dzwonczyk

Renita S. Rathinam

2100 Pennsylvania Ave., NW

Washington, DC 20037-3213

(202) 293-7060

mboland@sughrue.com

mdzwoncyzk@sughrue.com

rrathinam@sughrue.com

John B. Scherling

4250 Executive Square

Suite 900

La Jolla, CA 92037

(858) 795-1180

jscherling@sughrue.com

Attorneys for Defendants and CounterclaimPlaintiffs Hanmi USA, Inc., Hanmi Pharmaceutical 

Co., Ltd., Hanmi Fine Chemical Co., Ltd. and 

Hanmi Holdings Co., Ltd.

Case 3:11-cv-00760-JAP-TJB Document 290 Filed 04/29/13 Page 3 of 3 PageID: 10242